Analyst Research

Report Title Price
Fresenius Medical Care AG & Co. KGaA (FME) - Medical Equipment - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy
Fresenius Medical Care - Finlabo Research Equity Report: Fundamental and Technical Analysis and 6 months performance forecast
Provider: Finlabo SIM Spa
$58.00
Buy
Fresenius Medical AG ADS
Provider: S&P Capital IQ – STARS Reports
$115.00
Buy
Fresenius Medical Care AG & Co KGaA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Fresenius Medical Care AG & Co. KGaA Confirms FY 2012 Guidance


Wednesday, 1 Aug 2012 01:40am EDT 

Fresenius Medical Care AG & Co. KGaA announced that it confirms its fiscal year 2012 guidance. The Company expects revenue to grow to USD 14 billion in fiscal year 2012. Net income is expected to grow to USD 1.3 billion and net income attributable to shareholders of the Company is expected to grow to USD 1.14 billion. 

Latest Developments for Fresenius Medical Care AG & Co KGaA

Latest Key Developments in Healthcare

Company Quote

Fresenius Medical Care AG & Co KGaA
(FMEG.DE)
53.16
0.73 +1.39%
20 May 2013